Form 8-K - Current report:
SEC Accession No. 0001628280-20-000294
Filing Date
2020-01-10
Accepted
2020-01-10 17:29:29
Documents
3
Period of Report
2020-01-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kcaldolorrtulaunch.htm 8-K 38512
2 EXHIBIT 99.1 finalcaldolorrtulaunch.htm EX-99.1 37627
3 finalcaldolorrtulaunc_image1.jpg GRAPHIC 154948
  Complete submission text file 0001628280-20-000294.txt   290392
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 20522053
SIC: 2834 Pharmaceutical Preparations